🔎 Trials Near Me

Beranda › Kanker Prostat › Wisconsin

Uji klinis Kanker Prostat di Wisconsin

47 studi untuk Kanker Prostat mencari peserta di lokasi di Wisconsin.

Kota di Wisconsin

Teks studi resmi (Bahasa Inggris)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Wisconsin Carbone Cancer Center, Madison
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • ThedaCare Regional Cancer Center, Appleton
  • Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
  • dan 25 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 2 Okt 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Froedtert Menomonee Falls Hospital, Menomonee Falls
  • Medical College of Wisconsin, Milwaukee
  • Froedtert and MCW Moorland Reserve Health Center, New Berlin
  • dan 2 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 2 Okt 2026 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • ThedaCare Regional Cancer Center, Appleton
  • ThedaCare Regional Medical Center - Appleton, Appleton
  • dan 50 lainnya
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Marshfield Medical Center-Marshfield, Marshfield
  • Froedtert Menomonee Falls Hospital, Menomonee Falls
  • Medical College of Wisconsin, Milwaukee
  • dan 2 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06632977

PET/CT Characterization of Treatment Resistance

  • University of Wisconsin, Madison
Menerima peserta
Usia 18 ke atas · Pria · Diperbarui 1 Okt 2026 · NCT05647564

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Duluth Clinic Ashland, Ashland
  • Aurora Cancer Care-Southern Lakes VLCC, Burlington
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • dan 25 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT03866382

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • Medical College of Wisconsin ( Site 0020), Milwaukee
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 24 Sep 2026 · NCT07028853

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • Medical College Of Wisconsin, Milwaukee
Menerima pesertaFase 2/3
Usia 18 hingga 100 · Pria · Diperbarui 22 Sep 2026 · NCT06780670

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • Medical College of Wisconsin, Milwaukee
Menerima pesertaFase 3
Usia 18 hingga 100 · Pria · Diperbarui 22 Sep 2026 · NCT06855277

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  • William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 17 Sep 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 17 Sep 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • University Hospital and UW Health Clinics ( Site 0065), Madison
  • Medical College of Wisconsin ( Site 0008), Milwaukee
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 17 Sep 2026 · NCT06925737

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

  • Carbone Cancer Center University of Wisconsin-Madison, Madison
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 15 Sep 2026 · NCT06150417

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • University of Wisconsin, Madison
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 11 Sep 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Langlade Hospital and Cancer Center, Antigo
  • Duluth Clinic Ashland, Ashland
  • Northwest Wisconsin Cancer Center, Ashland
  • dan 36 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05946213

Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

  • Froedtert & the Medical College of Wisconsin, Milwaukee
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 9 Sep 2026 · NCT07226713

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

  • UW Health Carbone Cancer Center, Madison
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 3 Sep 2026 · NCT07005154

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Zablocki Veterans Administration Medical Center, Milwaukee
Menerima pesertaSukarelawan sehat diterima
Usia 45 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06995898

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT06582017

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

  • University of Wisconsin Carbone Cancer Center, Madison
Menerima pesertaStudi observasional
Usia 18 ke atas · Pria · Diperbarui 27 Agu 2026 · NCT07050433

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

  • University of Wisconsin Carbone Cancer Center-Madison, Madison
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 21 Agu 2026 · NCT06844383

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

  • Froedtert Hospital, Milwaukee
Menerima peserta
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07227077

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • University of Wisconsin Carbone Cancer Center - Johnson Creek, Johnson Creek
  • dan 13 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 19 Agu 2026 · NCT04423211

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of Wisconsin, Carbone Cancer Center, Madison
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  • University of Wisconsin Carbone Cancer Center, Madison
  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Menerima pesertaFase 1
Usia 18 hingga 100 · Pria · Diperbarui 13 Agu 2026 · NCT05519449

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

  • University of Wisconsin-Madison, Madison
Menerima pesertaStudi observasional
Usia 18 ke atas · Pria · Diperbarui 12 Agu 2026 · NCT04489719

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

  • Medical College of Wisconsin, Milwaukee
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 31 Jul 2026 · NCT06613100

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

  • Mayo Clinic Health System-Eau Claire, Eau Claire
  • Mayo Clinic Health System-Franciscan Healthcare, La Crosse
Menerima peserta
Usia 18 ke atas · Pria · Diperbarui 30 Jul 2026 · NCT06325046

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Duluth Clinic Ashland, Ashland
  • Northwest Wisconsin Cancer Center, Ashland
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • dan 10 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 14 Jul 2026 · NCT06592924

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Menerima pesertaFase 2
Usia 18 ke atas · Pria · Diperbarui 14 Jul 2026 · NCT05691465

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • University of Wisconsin, Madison
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 9 Jul 2026 · NCT07103018

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  • University of Wisconsin Carbone Cancer Center, Madison
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 9 Jul 2026 · NCT05413421

Integrated Cancer Repository for Cancer Research

  • Bellin Memorial Hospital, Green Bay
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699

Using FAPI PET/MRI to Evaluate Prostate Cancer

  • University of Wisconsin, Madison
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06675357

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

  • University of Wisconsin Carbone Cancer Center, Madison
Menerima pesertaStudi observasional
Usia 21 ke atas · Pria · Diperbarui 22 Mei 2026 · NCT03151629

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

  • William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
  • Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee
Menerima pesertaFase 2/3
Usia 18 ke atas · Pria · Diperbarui 8 Apr 2026 · NCT04787744

Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

  • University of Wisconsin Carbone Cancer Center (UWCCC) - Cancer Connect, Madison
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 20 Mar 2026 · NCT06705686

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

  • University of Wisconsin - Madison, Madison
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 11 Mar 2026 · NCT07090148

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.